Pointreau, Yoann <br/><br/>
Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer.  [electronic resource] 

 -  Therapeutic drug monitoring  10 2016 
 - 567-72 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1536-3694 
<br/><br/><label>Standard No.: </label>10.1097/FTD.0000000000000321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--blood<br/>Carcinoma, Squamous Cell--blood<br/>Cetuximab--blood<br/>Disease-Free Survival<br/>Female<br/>Head and Neck Neoplasms--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Retrospective Studies<br/>Squamous Cell Carcinoma of Head and Neck